ALKERMES, INC.
ALK37-003: A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation (OIC)
- Conditions
- Interventions
- First Posted Date
- 2010-04-08
- Last Posted Date
- 2011-08-23
- Lead Sponsor
- Alkermes, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT01100151
- Locations
- 🇺🇸
Alkermes Investigational Site, Salt Lake City, Utah, United States
🇺🇸Alkermes Investigative Site, New Smyrna Beach, Florida, United States
ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder
- First Posted Date
- 2010-04-02
- Last Posted Date
- 2011-08-23
- Lead Sponsor
- Alkermes, Inc.
- Target Recruit Count
- 69
- Registration Number
- NCT01098435
- Locations
- 🇺🇸
Alkermes' Investigational Study Site, Toledo, Ohio, United States
Study to Evaluate the Efficacy, Safety and Tolerability of N1539
- First Posted Date
- 2010-03-10
- Last Posted Date
- 2011-12-02
- Lead Sponsor
- Alkermes, Inc.
- Target Recruit Count
- 486
- Registration Number
- NCT01084161
ALK33-005: A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence
- Conditions
- Interventions
- First Posted Date
- 2009-09-22
- Last Posted Date
- 2011-08-23
- Lead Sponsor
- Alkermes, Inc.
- Target Recruit Count
- 406
- Registration Number
- NCT00981617
- Locations
- 🇺🇸
Alkermes Investigational Site, Middleton, Wisconsin, United States
🇺🇸Alkermes Investigational site, Hickory, North Carolina, United States
Single Dose Study of N1539 in the Treatment of Pain Secondary to Dental Impaction Surgery
- First Posted Date
- 2009-07-24
- Last Posted Date
- 2011-12-02
- Lead Sponsor
- Alkermes, Inc.
- Target Recruit Count
- 230
- Registration Number
- NCT00945763
- Locations
- 🇺🇸
Jean Brown Research, Salt Lake City, Utah, United States
ALK21-021: A Safety Study of Medisorb® Naltrexone (VIVITROL®) Administered to Health Care Professionals
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2018-12-11
- Lead Sponsor
- Alkermes, Inc.
- Target Recruit Count
- 38
- Registration Number
- NCT00834080
- Locations
- 🇺🇸
Alkermes Clinical Study Site, Dallas, Texas, United States
ALK29-002: A Study of Baclofen Formulations in Healthy Adults
- First Posted Date
- 2008-12-04
- Last Posted Date
- 2011-08-23
- Lead Sponsor
- Alkermes, Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT00802035
- Locations
- 🇺🇸
CEDRA Clinical Research, LLC, Austin, Texas, United States
ALK27-001: A Study of Trospium Inhalation Powder (TrIP)Administered to Subjects With COPD
- Conditions
- Interventions
- First Posted Date
- 2008-12-03
- Last Posted Date
- 2011-08-19
- Lead Sponsor
- Alkermes, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00801684
- Locations
- 🇺🇸
Spartanburg Medical Research, Spartanburg, South Carolina, United States
ALK33-001: A Study of RDC-0313 Administered to Healthy Adults
- First Posted Date
- 2008-12-02
- Last Posted Date
- 2011-08-22
- Lead Sponsor
- Alkermes, Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT00800319
- Locations
- 🇺🇸
Quintiles Phase One Services, Overland Park, Kansas, United States
ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid Dependence
- First Posted Date
- 2008-05-15
- Last Posted Date
- 2017-02-10
- Lead Sponsor
- Alkermes, Inc.
- Target Recruit Count
- 250
- Registration Number
- NCT00678418
- Locations
- 🇷🇺
Ethics Committee within the Federal Authority for Healthcare and Social Development Regulation, Moscow, Russian Federation